Drug intelligence / Profile preview

duhuo sanqi xiaotong granules

Development stage: Preclinical
Lead developer: The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Administration: Oral

Overview

Duhuo Sanqi Xiaotong granules is a traditional Chinese medicine (TCM) oral granule formulation used for the treatment of musculoskeletal conditions, including knee osteoarthritis, rheumatoid arthritis, and knee dysfunction due to trauma. It is also studied for improving clinical outcomes and relieving pain and inflammation post-knee arthroplasty when combined with physical therapy. The formulation is believed to contain active botanical components such as *Angelica pubescens* ('Duhuo') and *Panax notoginseng* ('Sanqi'), which are traditionally utilized in TCM to dispel wind-dampness, promote blood circulation, and alleviate joint pain.

Other names: Duhuo Sanqi Xiaotong Granules

Beyond the preview

Go deeper on duhuo sanqi xiaotong granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on duhuo sanqi xiaotong granules.

Explore the full profile